Keyphrases
Interferon-α (IFN-α)
100%
Therapeutic Target
100%
Colorectal Cancer
100%
Indoleamine 2,3-dioxygenase 1 (IDO1)
100%
Radiation Resistance
100%
Radiotherapy
27%
Radiation Effects
27%
Indoleamine 2,3-dioxygenase 1 Inhibitor
18%
Tumor
9%
Clinical Outcomes
9%
Overexpression
9%
Cancer Tumor
9%
Myeloid Cells
9%
Targeted Therapy
9%
Chemotherapy
9%
Intestinal Epithelium
9%
Syngeneic
9%
Type I IFN
9%
Mechanistic Insight
9%
Adjuvant Therapy
9%
Weight Loss
9%
Enzymatic Activity
9%
Tumor Microenvironment
9%
Th1 Cytokines
9%
Targeted Treatment
9%
Potential Treatments
9%
IFN Signaling
9%
Radiation Toxicity
9%
Radiation Sensitivity
9%
Induced Cell Death
9%
Radioprotection
9%
Causes of Mortality
9%
Radiation Field
9%
Locally Advanced Disease
9%
Kynurenine
9%
Organoids
9%
Tumorgraft
9%
Locally Advanced
9%
Colorectal Tissue
9%
Colorectal Cancer Cell Lines
9%
Abscopal Effect
9%
Modulating Factors
9%
Immuno-oncology
9%
Type II IFN
9%
Immune Targeting
9%
Epacadostat
9%
Accelerated Recovery
9%
Medicine and Dentistry
Interferon
100%
Radiosensitivity
100%
Colorectal Carcinoma
100%
Indoleamine 2,3 Dioxygenase
100%
Radiation Therapy
23%
Neoplasm
15%
Cytokine
7%
Myeloid Cell
7%
Cell Death
7%
Metabolite
7%
Enzyme Activity
7%
Radiation Protection
7%
Adjuvant Therapy
7%
Tumor Microenvironment
7%
Intestinal Epithelium
7%
Side Effect
7%
Radiation Toxicity
7%
Cancer Radiotherapy
7%
Organoid
7%
Immunity
7%
Kynurenine
7%
Cancer Tissue
7%
Abscopal Effect
7%
Epacadostat
7%
Colorectal Cancer Cell Line
7%
Diseases
7%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Colorectal Carcinoma
100%
Indoleamine 2,3 Dioxygenase
100%
Neoplasm
15%
Cytokine
7%
Chemotherapy
7%
Side Effect
7%
Tumor Microenvironment
7%
Kynurenine
7%
Radiation Toxicity
7%
Epacadostat
7%
Diseases
7%